Jan 04 by GJEL

Report: FDA Allowed Major Oversight Loopholes for DePuy Faulty Hip Implants

Late last year, the Food and Drug Administration announced that it would recall hip implants manufactured by DePuy Orthopedics, a division of pharmaceutical giant Johnson & Johnson due to an abnormally high number of hip implant failures, which some predicted could easily surpass 12,000. At the time, DePuy critics were quick to note that the ASR hip implant models hit the market without FDA oversight thanks to a loophole that greenlights a product if it is similar to a device already approved by the agency. Last month, the New York Times published a scathing report about DePuy and the FDA, showing just how easy it was for the J&J subsidiary to put a dangerous product on the market.

Read More
Nov 29 by GJEL

Faulty California Hip Surgeries Lead to DePuy Orthopedics Investigation

Two months ago, the Food and Drug Administration announced its recall of hip implants manufactured by DePuy Orthopedics, a division of Johnson & Johnson. Since, complaints about the recalled models have flooded in, leading some to predict that the total number of faulty hip surgeries could reach 12,000. Click through for more details and video.

Read More
Jun 08 by Ben

Citing Fires, General Motors Recalls 1.5 Million Cars

Your car’s definitely not supposed to catch on fire. Recognizing this, General Motors has announced a recall of nearly 1.5 million trucks and SUVs over windshield wiper fluid that can cause fires. In 2004, the National Highway Traffic Safety Administration investigated a similar windshield-wiper defect among GM models and fined the Detroit-based company $1 million for failing to conduct a timely recall.

Read More
Apr 19 by Ben

Toyota Will Recall Unsafe Lexus SUV, But Remains Rich

After a year of devastating PR stories that included unintended acceleration due to faulty car mats, delayed corporate reaction to potential recalls, and an additional forthcoming Lexus GX 460 recall, it turns out Toyota expects to post a $885 million net profit for the fiscal year that ended March 31.

Read More